Less invasive procedure offers an equally effective alternative for heart condition patients
News
PTC Therapeutic’s Upstaza has been recommended by both the EMA and CHMP
It is the first gene therapy to be directly administered into the brain to treat aromatic L-amino acid decarboxylase (AADC) deficiency
CHMP recommends Sanofi’s Xenpozyme for rare disease ASMD
Positive opinion is based on data from clinical trials which showed improvement in lung function
NICE recommends app-based treatment for insomnia over sleeping pills
Thousands usually prescribed sleeping pills could be offered app-based treatment
Birmingham research shows promise for spinal cord injury patients
Scientists demonstrated that AZD1236 halts oedema while reducing spinal cord breakdown at site of injury
Simple blood test could save thousands from bowel cancer
Comparisons with other tests available have shown that blood test has greater sensitivity for the detection of bowel cancer
The Baillie Gifford Pandemic Science Hub launched to fight lung disease
Gifford is supporting the launch with a philanthropic donation of £14.7m
Curebase and Flow Neuroscience launch clinical trial to test at-home headset for depression
Device delivers currents to the brain to restore activity usually lowered in depression patients
EpiEndo successfully completes phase 1 study into respiratory treatment
Orally available EP395 has met all endpoints in safety and is now undergoing phase 2 planning
MHRA marketing authorisation granted for Eli Lilly’s Verzenios as early breast cancer treatment
Authorisation of the treatment is based on results from the phase 3 trial
COVID-19 vaccine study focuses on young and immunosuppressed
Team at Imperial College London will expand MELODY study to include immunosuppressed young people
Sanofi’s Sarclisa combination shows positive results in multiple myeloma patients
Sarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells
Positive results for AstraZeneca’s asthma therapy
PT027 is being developed through a partnership involving AstraZeneca and Avillion
NHS patients missing out on new medicines that could extend lives
Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are missing out
NICE draft final guidance for Gedeon Richter UK’s new uterine fibroids treatment
The therapy offers patients a convenient alternative to surgery or injections and can be administered at home
